advice Flashcards
Allopurinol
1. MOA
2. Indication
3. Normal dose
4. Counsel
5. Warning signs (and action)
6. Renal/hepatic/P/BF/Child
- Reduce uric acid in body. xanthine oxidase inhibitor
- Gout PREVENTION (not tx - don’t start during acute attack), Kidney stones, hyperuricaemia due to chemotherapy (start before chemo)
- Normal dose: 100mg OD
- Counsel: after food, plenty of water
- warning signs: rash (stop - may be SJS)
- Metabolised in the liver and excreted by kidney. monitor renal/hepatic.
P-Y/BF-y
Interaction: Mercaptopurine, azathioprine (require xanthine oxidase) increased [m, a]
increased sensitivity with amoxicillin, ACEi, thiazide
Drug induced gout: thiazide or loop diuretics, Low-dose aspirin
Amitriptyline
1. TCA
2. Indication
3. Normal dose
4. Counsel
5. Warning signs (and action)
6. Renal/hepatic/P/BF/Child
- MOA
- Indication: pain (25-75mg), migraine prophylaxis (“), depression (50-150mg/2 doses)
- Lower dose in elderly. Titrate slowly (to reduce SE)
CI: arrhythmia, heart block, immediate after MI, manic phase - Counsel: keep taking. drowsy, dry mouth, constipation.
- Warning signs: fatal in overdose (Limit quantity), QT prolongations, anticholinergic syndrome. withdrawal effect (reduce over 4w)
- Avoid in severe hepatic. P-Y/BF-Y
THIAZIDE E.g bendroflumethiazide, indapamide
- Thiazide diuretics, inhibit the Na+/Cl− co-transporter in distal convoluted tubule of nephron.
- HTN 2.5mg OM, oedema 5-10mg OM
- lower dose for elderly,
- Counsel: OM. no NSAIDS. Possible impotence
Can exacerbate DM (hyperGlycaemia), gout (reduce UA excretion), SLE. - Warning signs: hyPOkalaemia, hyPOna -> arrythmia.
- Avoid in severe renal (<30ml/min) & NSAIDs reduce effectiveness
Interaction: loop (lower K), NSAID
Synergistic with ACE inhibitors and ARBs SE hyperkalaemia
Co-careldopa (carbidopa and levodopa) Cmg/Lmg
- Carbidopa, prevent LD from being broken down before reaches brain. LD convert into dopamine in brain.
- Parkinsons (rigidity and slow movement)
- BD, TDS, ensure ON time doses. MR may mitigate on-off effect. Avoid with large meal
when transferring, stop previous form for 12hr - Counsel: sudden onset of sleep. darker urine.
- Risk of impulse disorder, developing dopamine dysregulation syndrome; addiction-like symptoms - Report. Avoid abrupt withdrawal
MHRA: LD can cause impulse control disorder - Caution in Renal/hepatic/P. BF - avoid, suppress lactation
interaction: iron (1 hr window - reduce absorption)
Antipsychotics, metoclopramide as effects on dopamine receptors are contradictory.
Ferrous sulphate
- Body needs iron to make RBC
- iron deficiency anaemia prophylactic 200mg OD and Tx 200mg TDS
- lower dose in elderly
Continue for 3m to replenish stores. - Counsel: best absorbed on empty stomach. reduce SE with food. Darker stool.
SE: C/D/N, GI discomfort - Warning signs: faecal impaction.
Antidote: Desferrioxamine
Ispaghula husk
Ispaghula husk
1. Bulk forming, contains fibre, increasing faecal mass which stimulates peristalsis.
4. Counsel: avoid at night, Stir in >150ml of water & drink asap.
Adequate fluid to avoid oesophageal or intestinal obstruction.
5. CI: faecal impaction; intestinal obstruction; reduced gut motility
Lactulose
- Osmotic, stool softener
- Constipation, hepatic encephalopathy (reduces ammonia absorption)
- If necessary, it may be mixed with water, fruit juice or squash.
CI: GI obstruction/perforation, galactosaemia
SE: bloating, wind
Can increase Warfarin effect
Genitourinary anti-muscarinic - Oxybutynin, solifenacin
- Overactive bladder
- review every 6w until stable symptoms, then 6mly
- w//out food. ensure drinking enough water.
SE: Drowsy, dry mouth, constipation, facial flushing.
CI in AM (glaucoma, myasthenia gravis), acute porphyria - CAUTION in Renal/hepatic. P-N/BF-N/Child (>5)
Interaction: TCA (increase AM SE)
Solifenacin
max 5mg OD if <30mL/min, moderate hepatic, with potent 3A4 inhibitor. avoid in severe hepatic.
QT? prolongation
Counsel: with water (other drinks may release solifenacin in mouth)
Quinine for cramps
- Cramps prophylaxis 200-300mg ON (4w trial),
Malaria (Plasmodium falciparum) Xmg/kg (dose not valid for quinine bisulfate) reduce parental dose in severe H/R - IV dose based on weight and given as slow infusion
- Counsel: takes weeks to work.
- Warning signs: unusual itching, rash, deafness or blindness, palpitations. Teratogenic.
OVERDOSE: arrythmia, convulsions
MHRA: Dose-dependent QT-interval-prolonging effects. Monitor ECG during parental tx
CI: Haemoglobinuria; myasthenia gravis; optic neuritis; tinnitus, G6PD deficiency - Renal reduce/hepatic/P-malaria RvB/BF-Y
interaction: QT (amiodarone, antipsychotics, quinolones, macrolides, SSRIs.)
Exclude: electrolyte disturbances, drug causes (e.g. statins, β2-agonists), and attempt stretching
Tamoxifen
- Anti-oestrogen
- Infertility, breast cancer prophylaxis.
- 20mg OD (once weekly for gynaecomastia - UL)
- Counsel: contraception, endometrial cancer (vaginal bleed, pelvic pain), thromboembolism (breathless, pain in one leg)
- CI if hx of VTE
SE: hot flushes, nausea, vision problems, genital itching
WARNING SIGN: endometrial changes, risk of VTE
P-N/BF-N supress lactation